Welcome to LookChem.com Sign In|Join Free

CAS

  • or

279250-90-7

Post Buying Request

279250-90-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

279250-90-7 Usage

Physical form

white to off-white crystalline solid

Uses

synthesis of pharmaceuticals and agrochemicals

Biological and pharmacological properties

+ carbonic anhydrase inhibitor
+ anti-tumor agent

Potential treatments

+ cancer
+ inflammation
+ microbial infections

Value in research and development

unique structure and properties make it valuable in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 279250-90-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,9,2,5 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 279250-90:
(8*2)+(7*7)+(6*9)+(5*2)+(4*5)+(3*0)+(2*9)+(1*0)=167
167 % 10 = 7
So 279250-90-7 is a valid CAS Registry Number.

279250-90-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(2-thiazolyl)-4-cyano-1H-imidazole

1.2 Other means of identification

Product number -
Other names 2-thiazol-2-yl-1H-imidazole-4-carbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:279250-90-7 SDS

279250-90-7Relevant articles and documents

2-ARYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS

-

Page/Page column 36-37, (2011/07/07)

This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The pr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 279250-90-7